Distribution of SRPK1 in human brain

Journal of Chemical Neuroanatomy

Volumn 43, Issue 1, 2012, Pages 20-27

  Mytilinaios, D G ^a,b   Tsamis, K I ^a   Nikolakaki, E ^a   Giannakouros, T ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Alternative splicing; Neurotransmitter receptors; SRPK1

Indexed keywords

PROTEIN KINASE; SERINE ARGININE PROTEIN KINASE 1; SERINE ARGININE RICH PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN; CELLULAR DISTRIBUTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING;

AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; BRAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURONS; ORGAN SPECIFICITY; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES;

EID: 84856544747     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2011.10.002     Document Type: Article

References (26)

1. Andreadis A. Tau splicing and the intricacies of dementia. J. Cell. Physiol. 2011, (Epub ahead of print). 10.1002/jcp.22842.
2. Caceres J.F., Stamm S., Helfman D.M., Krainer A.R. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 1994, 265:1706-1709.
3. Crovato T.E., Egebjerg J. ASF/SF2 and SC35 regulate the glutamate receptor subunit 2 alternative flip/flop splicing. FEBS Lett. 2005, 579:4138-4144.
4. Ding J.H., Zhong X.Y., Hagopian J.C., Cruz M.M., Ghosh G., Feramisco J., Adams J.A., Fu X.D. Regulated cellular partitioning of SR protein-specific kinases in mammalian cells. Mol. Biol. Cell 2006, 17:876-885.
5. Erdö F., Trapp T., Mies G., Hossmann K.A. Immunohistochemical analysis of protein expression after middle cerebral artery occlusion in mice. Acta Neuropathol. 2004, 107:127-136.
6. Feng Y., Chen M., Manley J.L. Phosphorylation switches the general splicing repressor SRp38 to a sequence-specific activator. Nat. Struct. Mol. Biol. 2008, 15:1040-1048.
7. Giannakouros T., Nikolakaki E., Mylonis I., Georgatsou E. Serine-arginine protein kinases: a small protein kinase family with a large cellular presence. FEBS J. 2011, 278:570-586.
8. Graveley B.R. Alternative splicing: increasing diversity in the proteomic world. Trends Genet. 2001, 17:100-107.
9. Grabowski P.J., Black D.L. Alternative RNA splicing in the nervous system. Prog. Neurobiol. 2001, 65:289-308.
10. Hartmann A.M., Rujescu D., Giannakouros T., Nikolakaki E., Goedert M., Mandelkow E.M., Gao Q.S., Andreadis A., Stamm S. Regulation of alternative splicing of human tau exon 10 by phosphorylation of splicing factors. Mol. Cell. Neurosci. 2001, 18:80-90.
11. Hayes G.M., Carrigan P.E., Beck A.M., Miller L.J. Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma. Cancer Res. 2006, 66:3819-3827.
12. Karakama Y., Sakamoto N., Itsui Y., Nakagawa M., Tasaka-Fujita M., Nishimura-Sakurai Y., Kakinuma S., Oooka M., Azuma S., Tsuchiya K., Onogi H., Hagiwara M., Watanabe M. Inhibition of hepatitis C virus replication by a specific inhibitor of serine-arginine-rich protein kinase. Antimicrob. Agents Chemother. 2010, 54:3179-3186.
13. Krishnakumar S., Mohan A., Kandalam M., Ramkumar H.L., Venkatesan N., Das R.R. SRPK1: a cisplatin sensitive protein expressed in retinoblastoma. Pediatr. Blood Cancer 2008, 50:402-406.
14. Lai M.C., Lin R.I., Huang S.Y., Tsai C.W., Tarn W.Y. A human importin-beta family protein, transportin-SR2, interacts with the phosphorylated RS domain of SR proteins. J. Biol. Chem. 2000, 275:7950-7957.
15. Li Q., Lee J.A., Black D.L. Neuronal regulation of alternative pre-mRNA splicing. Nat. Rev. Neurosci. 2007, 8:819-831.
16. Liu L., Lin J.J., Chen X., Liu X., Xu P. Neural expression and regulation of NSSR1 proteins. Neuroreport 2003, 14:1847-1850.
17. Loya C.M., Van Vactor D., Fulga T.A. Understanding neuronal connectivity through the post-transcriptional toolkit. Genes Dev. 2010, 24:625-635.
18. Schenk P.W., Stoop H., Bokemeyer C., Mayer F., Stoter G., Oosterhuis J.W., Wiemer E., Looijenga L.H., Nooter K. Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1. Neoplasia 2004, 6:297-301.
19. Shi Y., Manley J.L. A complex signaling pathway regulates SRp38 phosphorylation and pre-mRNA splicing in response to heat shock. Mol. Cell 2007, 28:79-90.
20. Shi S.R., Chaiwun B., Young L., Cote R.J., Taylor C.R. Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J. Histochem. Cytochem. 1993, 41:1599-1604.
21. Tazi J., Bakkour N., Stamm S. Alternative splicing and disease. Biochim. Biophys. Acta 2009, 1792:14-26.
22. Wang J., Manley J.L. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1995, 1:335-346.
23. Xiao S.H., Manley J.L. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev. 1997, 11:334-344.
24. Zahler A.M., Neugebauer K.M., Lane W.S., Roth M.B. Distinct functions of SR proteins in alternative pre-mRNA splicing. Science 1993, 260:219-222.
25. Zhong X.Y., Wang P., Han J., Rosenfeld M.G., Fu X.D. SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. Mol. Cell 2009, 35:1-10.
26. Zhong X.Y., Ding J.H., Adams J.A., Ghosh G., Fu X.D. Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones. Genes Dev. 2009, 23:482-495.